| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Turning Point Therapeutics Inc (NASDAQ: TPTX)
TPTX Technical Analysis
3
| As on 7th Sep 2022 TPTX SHARE Price closed @ 76.01 and we RECOMMEND Buy for LONG-TERM with Stoploss of 60.28 & Buy for SHORT-TERM with Stoploss of 75.13 we also expect STOCK to react on Following IMPORTANT LEVELS. |
TPTXSHARE Price
| Open | 76.01 | Change | Price | % |
| High | 76.01 | 1 Day | 0.00 | 0.00 |
| Low | 76.01 | 1 Week | 0.00 | 0.00 |
| Close | 76.01 | 1 Month | 1.14 | 1.52 |
| Volume | N/A | 1 Year | -18.01 | -19.16 |
| 52 Week High 97.70 | 52 Week Low 24.32 | ||||
NASDAQ USA Most Active Stocks
| AMRS | 0.14 | 100.00% |
| NVDA | 173.72 | -2.33% |
| OPEN | 2.10 | 14.13% |
| EQ | 0.71 | 82.05% |
| AMZN | 214.75 | -8.27% |
| NCNA | 0.04 | 0.00% |
| LMDX | 0.02 | 0.00% |
| BTAI | 1.37 | 4.58% |
| AKTS | 0.04 | 0.00% |
| AAPL | 202.38 | -2.50% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| TPTX Daily Charts |
TPTX Intraday Charts |
Whats New @ Bazaartrend |
TPTX Free Analysis |
|
|
TPTX Important Levels Intraday
| RESISTANCE | 76.01 |
| RESISTANCE | 76.01 |
| RESISTANCE | 76.01 |
| RESISTANCE | 76.01 |
| RESISTANCE | 76.01 |
| RESISTANCE | 76.01 |
| RESISTANCE | 76.01 |
| RESISTANCE | 76.01 |
TPTX Forecast August 2025
| 4th UP Forecast | 144.59 |
| 3rd UP Forecast | 122.6 |
| 2nd UP Forecast | 109 |
| 1st UP Forecast | 95.41 |
| 1st DOWN Forecast | 56.61 |
| 2nd DOWN Forecast | 43.02 |
| 3rd DOWN Forecast | 29.42 |
| 4th DOWN Forecast | 7.43 |
TPTX Weekly Forecast
| 4th UP Forecast | 109.60 |
| 3rd UP Forecast | 98.83 |
| 2nd UP Forecast | 92.17 |
| 1st UP Forecast | 85.51 |
| 1st DOWN Forecast | 66.51 |
| 2nd DOWN Forecast | 59.85 |
| 3rd DOWN Forecast | 53.19 |
| 4th DOWN Forecast | 42.42 |
TPTX Forecast2025
| 4th UP Forecast | 216.43 |
| 3rd UP Forecast | 171.4 |
| 2nd UP Forecast | 143.56 |
| 1st UP Forecast | 115.72 |
| 1st DOWN Forecast | 36.3 |
| 2nd DOWN Forecast | 8.46 |
| 3rd DOWN Forecast | -19.38 |
| 4th DOWN Forecast | -64.41 |
Turning Point Therapeutics Inc ( NASDAQ USA Symbol : TPTX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
TPTX Business Profile
Turning Point Therapeutics, Inc., a clinical-stage precision oncology biopharmaceutical company, engages in designing and developing therapies that target genetic drivers of cancer. It develops a pipeline of tyrosine kinase inhibitors (TKIs) that targets genetic drivers of cancer in TKI-naïve and TKI-pretreated patients. The company's lead drug candidate repotrectinib is being evaluated in an ongoing Phase 1/2 trial called TRIDENT-1 for the treatment of patients with ROS1+ advanced non-small-cell lung cancer (NSCLC) and patients with ROS1+, NTRK+, or ALK+ advanced solid tumors. Its pipeline also includes multi-targeted drug candidates TPX-0022, a MET/CSF1R/SRC inhibitor, which is in Phase 1 SHIELD-1 clinical trial for patients with advanced solid tumors harboring genetic alterations in MET; TPX-0046, a RET inhibitor that is in Phase 1/2 clinical trial for patients with advanced solid tumors harboring RET genetic alterations; and TPX-0131, a preclinical ALK inhibitor for advanced non-small-cell lung cancer. The company was founded in 2013 and is headquartered in San Diego, California. Address: 10628 Science Center Drive, San Diego, CA, United States, 92121
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service